GRIFOLS, S.A. is a global healthcare company founded in Barcelona in 1909. It specializes in developing and producing plasma-derived medicines and biopharmaceutical solutions to treat patients with chronic, rare, and life-threatening conditions. The company operates a network of plasma donation centers - the largest in the world - spanning North America, Europe, Africa, the Middle East, and China.
For nursing and clinical professionals, Grifols offers a range of products relevant to transfusion medicine and diagnostics. Its portfolio includes solutions designed to enhance safety throughout the donation-to-transfusion process, as well as clinical diagnostic technologies used in healthcare settings. The company also supplies biological materials for life-science research and pharmaceutical manufacturing.
With a workforce of over 23,000 employees across more than 30 countries and regions, Grifols maintains a presence in more than 110 countries. Its technical work spans plasma-derived medicine, biopharmaceutical solutions, transfusion medicine, clinical diagnostics, and biological supplies for research and manufacturing.
